Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience

Background and Aims: Patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) who are dialysis-dependent form a unique group, in which safety, tolerability and efficacy of sofosbuvir (SOF)-based direct-acting antivirals (DAAs) need further evaluation. Methods: We performed a retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Avin, Yoo, Eric R., Perumpail, Ryan B., Cholankeril, George, Kumari, Radhika, Daugherty, Tami J., Lapasaran, Alex S., Ahmed, Aijaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411352/
https://www.ncbi.nlm.nih.gov/pubmed/28507922
http://dx.doi.org/10.14218/JCTH.2016.00060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411352/
https://www.ncbi.nlm.nih.gov/pubmed/28507922
http://dx.doi.org/10.14218/JCTH.2016.00060

Ejemplares similares